The ability of anaesthetists to identify generic medications from trade names

Anaesthesia and Intensive Care

Volumn 37, Issue 4, 2009, Pages 624-629

  Bramley, D E P ^a,b  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b WESTERN HOSPITAL   (Australia)

Author keywords

Drug identification; Drugs; Generic names; Medications; Therapeutic groups; Trade names

Indexed keywords

ACETYLSALICYLIC ACID; ACIMAX; ANTIHYPERTENSIVE AGENT; ATENOLOL; AVANZA; BUPRENORPHINE; CARTIA; CARVEDILOL; CITALOPRAM; CLOPIDOGREL; FELODIPINE; GLICLAZIDE; GLYADE; IBUPROFEN; IRBESARTAN; LANSOPRAZOLE; MELOXICAM; METFORMIN; METOPROLOL; MINAX; MIRTAZIPINE; MURELAX; OMEPRAZOLE; OXAZEPAM; PAROXETINE; PERINDOPRIL; RISPERIDONE; ROSIGLITAZONE; SIMVASTATIN; TALAM; TELMISARTAN; TENSIG; TRAMADOL; UNCLASSIFIED DRUG; VERAPAMIL; WARFARIN;

DRUG IDENTIFICATION; HEALTH CARE; MEDICAL EDUCATION; MEDICAL PRACTICE; MEDICAL PROFESSION; PRESCRIPTION; REVIEW; STRUCTURED QUESTIONNAIRE;

EID: 67649670144     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700401     Document Type: Review

References (28)

1. Recommendations on the Pre-Anaesthesia Consultation. ANZCA Professional Documents: Professional Standards Melbourne, Australia 2003.
2. Lambert BL, Lin SJ, Tan H. Designing safe drug names. Drug Safety 2005; 28:495-512. (Pubitemid 41003055)
3. Rataboli PV, Garg A. Confusing brand names: nightmare of medical profession. J Postgrad Med 2005; 51:13-16. (Pubitemid 40976022)
4. Hampton T. Similar drug names a risky prescription. JAMA 2004; 291:1948-1949. (Pubitemid 38544271)
5. Aronson JK. Medication errors resulting from the confusion of drug names. Expert Opin Drug Saf 2004; 3:167-172. (Pubitemid 38765199)
6. Rados C. Drug name confusion: preventing medication errors. FDA Consum 2005; 39:35-37. (Pubitemid 41297097)
7. Wheeler SJ, Wheeler DW. Medication errors in anaesthesia and critical care. Anaesthesia 2005; 60:257-273. (Pubitemid 40310207)
8. Abeysekera A, Bergman IJ, Kluger MT, Short TG. Drug error in anaesthetic practice: a review of 896 reports from the Australian Incident Monitoring Study database. Anaesthesia 2005; 60:220-227. (Pubitemid 40310201)
9. Passmore C, Dobbie AE, Parchman M, Tysinger J. Guidelines for constructing a survey. Fam Med 2002; 34:281-286. (Pubitemid 34273430)
10. Boynton PM, Greenhalgh T. Selecting, designing, and developing your questionnaire. BMJ 2004; 328:1312-1315.
11. Jones D, Story D, Clavisi O, Jones R, Peyton P. An introductory guide to survey research in anaesthesia. Anaesth Intensive Care 2006; 34:245-253.
12. PBS Expenditure and Prescriptions to June 2005. Available from http://www.health.gov.au/internet/wcms/publishing.nsf/Content/ pbs-stats-pbexp-jun05-index1 Accessed March 2006.
13. Guidelines on the Use of International Non-Proprietary Names (INN) for Pharmaceutical Substances. Division of Drug Management and Policies, World Health Organisation. Geneva (1997).
14. TGA Approved Terminology for Medicines - July 1999 (and amendments). Department of Health and Ageing, Commonwealth of Australia, 1999.
15. Birkett DJ. Generics - equal or not? Aust Prescr 2003; 26:85-87.
16. Berman A . Reducing medication errors through naming, labeling, and packaging. J Med Syst 2004; 28:9-29. (Pubitemid 39012178)
17. Guideline on the Acceptability of Invented Names for Human Medicinal Products Processed Through the Centralised Procedure. Human Medicines Evaluation Unit, European Medicines Agency 2004.
18. Strategies to Reduce Medication Errors, FDA Consumer Magazine, May-June 2003.
19. Best practice guideline on prescription medicine labelling. Drug Safety and Evaluation Branch (DSEB) of the Therapeutic Goods Administration (TGA). Department of Health and Ageing, Commonwealth of Australia, November 2005.
20. Consumers Filling U.S. Prescriptions Abroad May Get the Wrong Active Ingredient Because of Confusing Drug Names. Food and Drug Administration Health Advisory, USA, January 2006.
21. Department of Health and Ageing. Available from http://www.aph.gov.au/ library/intguide/SP/pbs.htm Accessed March 2006.
22. Australian Statistics on Medicine 2003. Department of Health and Ageing, Commonwealth of Australia, 2005.
23. Pharmaceutical Benefits Pricing Authority Annual report, June 2005.
24. Schwab M, Oetzel C, Mörike K, Jägle C, Gleiter CH, Eichelbaum M. Using trade names: a risk factor for accidental drug overdose. Arch Intern Med 2002; 162:1065-1066. (Pubitemid 34492538)
25. Dean B, Schachter M, Vincent C, Barber N. Causes of prescribing errors in hospital inpatients: a prospective study. Lancet 2002; 359:1373-1378. (Pubitemid 34442377)
26. Dickman A. Branded prescribing of strong opioids should be adopted as good practice. The Pharmaceutical Journal 2005; Vol.275 p. 546 Available from www.pjonline.com Accessed June 2006. (Pubitemid 41645269)
27. Anton C, Cox AR, Ferner RE. Using trade names: sometimes it helps. Arch Intern Med 2002; 162:2636. (Pubitemid 35453513)
28. Myles P, Gin T. Statistical Methods in Anaesthesia and Intensive care. Butterworth Heineman, Oxford 2000.